β-Estradiol and progesterone enhance biofilm development and persister cell formation in monospecies and microcosms biofilms derived from vulvovaginal candidiasis

References

• Al-Dhaheri RS, Douglas LJ. 2008. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother. 52:1884–1887. doi: 10.1128/AAC.01473-07.
   PubMed Web of Science ®Google Scholar
• Alves CT, Silva S, Pereira L, Williams DW, Azeredo J, Henriques M. 2014. Effect of progesterone on Candida albicans vaginal pathogenicity. Int J Med Microbiol. 304:1011–1017. doi: 10.1016/j.ijmm.2014.07.004.
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Daneshnia F, Cabrera N, Penalva-Lopez S, Sarathy J, Zimmerman M, Shor E, Perlin DS. 2023. Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance. Nat Commun. 14:1183. doi: 10.1038/s41467-023-36882-6.
   PubMed Web of Science ®Google Scholar
• Boatto HF, Girão MJBC, Francisco EC, Machado AP, Moraes MS, Fischman O. 2016. Susceptibility to fluconazole and ketoconazole of Candida spp. isolated from primary and episodic vulvovaginites by e-test (São Paulo, SP, Brazil). OJOG. 06:689–697. doi: 10.4236/ojog.2016.612086.
   Google Scholar
• Brandão LDS, Boniek D, Resende Stoianoff MA, Da Mata FMR, De Azevedo PRM, Fernandes JV, Andrade VS. 2018. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil. Lett Appl Microbiol. 67:285–291. doi: 10.1111/lam.13034.
   PubMed Web of Science ®Google Scholar
• Brandolt TM, Klafke GB, Gonçalves CV, Bitencourt LR, Martinez AM, Mendes JF, Meireles MC, Xavier MO. 2017. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol. 48:145–150. doi: 10.1016/j.bjm.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Carvalho GC, de Oliveira RAP, Araujo VHS, Sábio RM, de Carvalho LR, Bauab TM, Corrêa I, Chorilli M. 2021. Prevalence of vulvovaginal candidiasis in Brazil: systematic review. Med Mycol. 59:946–957. doi: 10.1093/mmy/myab034.
   PubMed Web of Science ®Google Scholar
• Cheng G, Yeater KM, Hoyer LL. 2006. Cellular and molecular biology of Candida albicans estrogen response. Eukaryot Cell. 5:180–191. doi: 10.1128/EC.5.1.180-191.2006.
   PubMed Web of Science ®Google Scholar
• Cordeiro RdA, de Andrade ARC, Portela FVM, Pereira LMG, Moura SGB, Sampaio MD, Pereira EMA, de Melo Guedes GM, Bandeira SP, de Lima-Neto RG, et al. 2020. Proposal for a microcosm biofilm model for the study of vulvovaginal candidiasis. Biofouling. 36:610–620. doi: 10.1080/08927014.2020.1785435.
   PubMed Web of Science ®Google Scholar
• Czechowicz P, Nowicka J, Gościniak G. 2022. Virulence factors of Candida spp. and host immune response important in the pathogenesis of vulvovaginal candidiasis. Int J Mol Sci. 23:5895. doi: 10.3390/ijms23115895.
   PubMed Web of Science ®Google Scholar
• Denega I, d‘Enfert C, Bachellier-Bassi S. 2019. Candida albicans biofilms are generally devoid of persister cells. Antimicrob Agents Chemother. 63:e01979-18. doi: 10.1128/AAC.01979-18.
   PubMed Web of Science ®Google Scholar
• Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. 2018. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 18:e339–e347. doi: 10.1016/S1473-3099(18)30103-8.
   PubMed Web of Science ®Google Scholar
• Fornari G, Vicente VA, Gomes RR, Muro MD, Pinheiro RL, Ferrari C, Herkert PF, Takimura M, Carvalho NS, Queiroz-Telles F. 2016. Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis. Braz J Microbiol. 47:373–380. doi: 10.1016/j.bjm.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. 2016. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 42:905–927. doi: 10.3109/1040841X.2015.1091805.
   PubMed Web of Science ®Google Scholar
• Gonçalves B, Azevedo NM, Henriques M, Silva S. 2020a. Hormones modulate Candida vaginal isolates biofilm formation and decrease their susceptibility to azoles and hydrogen peroxide. Med Mycol. 58:341–350. doi: 10.1093/mmy/myz070.
   PubMed Web of Science ®Google Scholar
• Gonçalves B, Bernardo R, Wang C, Schröder MS, Pedro NA, Butler G, Azeredo J, Henriques M, Pereira Mira N, Silva S. 2020b. Effect of progesterone on Candida albicans biofilm formation under acidic conditions: a transcriptomic analysis. Int J Med Microbiol. 310:151414. doi: 10.1016/j.ijmm.2020.151414.
   PubMed Web of Science ®Google Scholar
• Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC. 2010. Candida albicans forms biofilms on the vaginal mucosa. Microbiol (Reading). 156:3635–3644. doi: 10.1099/mic.0.039354-0.
   PubMed Web of Science ®Google Scholar
• He Y, Tang R, Deng J, Cai T, He P, Wu J, Cao Y. 2022. Effects of oestrogen on vulvovaginal candidosis. Mycoses. 65:4–12. doi: 10.1111/myc.13385.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh L, Ranjbar M, Nazari T, Naeimi Eshkaleti M, Aghaei Gharehbolagh S, Sobel JD, Mahmoudi S. 2022. Vulvovaginal candidiasis: an overview of mycological, clinical, and immunological aspects. J Obstet Gynaecol Res. 48:1546–1560. doi: 10.1111/jog.15267.
   PubMed Web of Science ®Google Scholar
• Kinsman OS, Pitblado K, Coulson CJ. 1988. Effect of mammalian steroid hormones and luteinizing hormone on the germination of Candida albicans and implications for vaginal candidosis. Mycoses. 31:617–626. doi: 10.1111/j.1439-0507.1988.tb04416.x.
   PubMed Web of Science ®Google Scholar
• Kumwenda P, Cottier F, Hendry AC, Kneafsey D, Keevan B, Gallagher H, Tsai HJ, Hall RA. 2022. Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system. Cell Rep. 38:110183. doi: 10.1016/j.celrep.2021.110183.
   PubMed Web of Science ®Google Scholar
• LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother. 50:3839–3846. doi: 10.1128/AAC.00684-06.
   PubMed Web of Science ®Google Scholar
• Lima-Neto R, Cledir SC, Lima N, Sampaio P, País C, Neves RP. 2014. Application of MALDI-TOF MS for requalification of a Candida clinical isolates culture collection. Braz J Microbiol. 45:515–522. doi: 10.1590/S1517-83822014005000044.
   PubMed Web of Science ®Google Scholar
• Lopes JP, Lionakis MS. 2022. Pathogenesis and virulence of Candida albicans. Virulence. 13:89–121. doi: 10.1080/21505594.2021.2019950.
   PubMed Web of Science ®Google Scholar
• Luan T, Liu X, Mao P, Wang X, Rui C, Yan L, Wang Y, Fan C, Li P, Zeng X. 2020. The role of 17β-estrogen in Candida albicans adhesion on human vaginal epithelial cells via FAK phosphorylation. Mycopathologia. 185:425–438. doi: 10.1007/s11046-020-00440-1.
   PubMed Web of Science ®Google Scholar
• McKloud E, Delaney C, Sherry L, Kean R, Williams S, Metcalfe R, Thomas R, Richardson R, Gerasimidis K, Nile CJ, et al. 2021. Recurrent vulvovaginal candidiasis: a dynamic interkingdom biofilm disease of Candida and Lactobacillus. mSystems. 6:e0062221. doi: 10.1128/mSystems.00622-21.
   PubMed Web of Science ®Google Scholar
• Muzny CA, Schwebke JR. 2015. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin Infect Dis. 61:601–606. doi: 10.1093/cid/civ353.
   PubMed Web of Science ®Google Scholar
• Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. 2022. Vulvovaginal candidiasis: a review of the evidence for the 2021 Centers for Disease Control and Prevention of sexually transmitted infections treatment guidelines. Clin Infect Dis. 74:S162–S168. doi: 10.1093/cid/ciab1057.
   PubMed Web of Science ®Google Scholar
• Peeters E, Nelis HJ, Coenye T. 2008. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods. 72:157–165. doi: 10.1016/j.mimet.2007.11.010.
   PubMed Web of Science ®Google Scholar
• Polke M, Hube B, Jacobsen ID. 2015. Candida survival strategies. Adv Appl Microbiol. 91:139–235. doi: 10.1016/bs.aambs.2014.12.002.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, López-Barcenas A, Fabbrocini G, Bardhi B, Sinani A, Sánchez-Blanco E, Arenas-Guzmán R, Hernandez-Castro R. 2019. Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces. 174:110–125. doi: 10.1016/j.colsurfb.2018.11.011.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Cerdeira C, Martínez-Herrera E, Gregorio MC, López-Barcenas A, Fabbrocini G, Fida M, El-Samahy M, González-Cespón JL. 2020. Pathogenesis and clinical relevance of Candida biofilms in vulvovaginal candidiasis. Front Microbiol. 11:544480. doi: 10.3389/fmicb.2020.544480.
   PubMed Web of Science ®Google Scholar
• Sherry L, Kean R, McKloud E, O'Donnell LE, Metcalfe R, Jones BL, Ramage G. 2017. Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole. Antimicrob Agents Chemother. 61:1–14. doi: 10.1128/AAC.01065-17.
   Web of Science ®Google Scholar
• Sobel JD. 2016. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 214:15–21. doi: 10.1016/j.ajog.2015.06.067.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Sobel R. 2018. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 19:971–977. doi: 10.1080/14656566.2018.1476490.
   PubMed Web of Science ®Google Scholar
• Tobudic S, Kratzer C, Lassnigg A, Presterl E. 2012. Antifungal susceptibility of Candida albicans in biofilms. Mycoses. 55:199–204. doi: 10.1111/j.1439-0507.2011.02076.x.
   PubMed Web of Science ®Google Scholar
• Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P. 2019. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 52:1–6. doi: 10.1016/j.mib.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Wainwright J, Hobbs G, Nakouti I. 2021. Persister cells: formation, resuscitation and combative therapies. Arch Microbiol. 203:5899–5906. doi: 10.1007/s00203-021-02585-z.
   PubMed Web of Science ®Google Scholar
• Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. 2020. Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi (Basel). 6:27. doi: 10.3390/jof6010027.
   PubMedGoogle Scholar
• Wu X, Zhang S, Li H, Shen L, Dong C, Sun Y, Chen H, Xu B, Zhuang W, Deighton M, et al. 2020. Biofilm formation of Candida albicans facilitates fungal infiltration and persister cell formation in vaginal candidiasis. Front Microbiol. 11:1117. doi: 10.3389/fmicb.2020.01117.
   PubMed Web of Science ®Google Scholar
• Wuyts J, Van Dijck P, Holtappels M. 2018. Fungal persister cells: the basis for recalcitrant infections? PLoS Pathog. 14:e1007301. doi: 10.1371/journal.ppat.1007301.
   PubMed Web of Science ®Google Scholar
• Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, Noverr MC, Fidel PL. Jr. 2019. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 19:48. doi: 10.1186/s12905-019-0748-8.
   PubMed Web of Science ®Google Scholar